TVARDI THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CARA)

42 filings reported holding CARA - TVARDI THERAPEUTICS, INC. - Common Stock, par value $0.001 per share as of Q1 2025.
TVARDI THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (CARA) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 633,363 shares of 9,346,119 outstanding shares and own 6.8% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (168,101 shares), FARALLON CAPITAL MANAGEMENT LLC (129,685 shares), RENAISSANCE TECHNOLOGIES LLC (88,530 shares), BlackRock, Inc. (61,869 shares), TWO SIGMA ADVISERS, LP (49,180 shares), GEODE CAPITAL MANAGEMENT, LLC (39,366 shares), BANK OF AMERICA CORP /DE/ (27,046 shares), UBS Group AG (19,101 shares), MILLENNIUM MANAGEMENT LLC (17,420 shares), and STATE STREET CORP (14,889 shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.